REQUEST A DEMO
Total
USD $0.00
Search more companies

Safpure Lifesciences Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Safpure Lifesciences Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Safpure Lifesciences Private Limited is an unlisted company, incorporated on 22/04/2013. It has its registered office in the State of Rajasthan, India. Company's corporate identification number (CIN) is U24232RJ2013PTC042203 and registration number is 042203. The company is a trade company, it is engaged in retail trading.

Legal Address
C/O Kishan Khandelwal Bapu Nagar
Ajmer; Rajasthan; Postal Code: 305624

Contact Details: Purchase the Safpure Lifesciences Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Safpure Lifesciences Private Limited report to view the information.
Registered Capital:
Purchase the Safpure Lifesciences Private Limited report to view the information.
Incorporation Date:
April 22, 2013
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Safpure Lifesciences Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
119.53%
Total operating revenue
122.99%
Operating profit (EBIT)
268.8%
EBITDA
236.09%
Net Profit (Loss) for the Period
268.8%
Total assets
10.64%
Total equity
68.82%
Operating Profit Margin (ROS)
0.09%
Net Profit Margin
0.09%
Return on Equity (ROE)
22.11%
Debt to Equity Ratio
-857.91%
Quick Ratio
-4%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?